U.S. markets open in 1 hour 30 minutes
  • S&P Futures

    4,353.25
    -68.50 (-1.55%)
     
  • Dow Futures

    33,848.00
    -614.00 (-1.78%)
     
  • Nasdaq Futures

    15,106.50
    -219.50 (-1.43%)
     
  • Russell 2000 Futures

    2,180.40
    -47.90 (-2.15%)
     
  • Crude Oil

    70.42
    -1.55 (-2.15%)
     
  • Gold

    1,755.70
    +4.30 (+0.25%)
     
  • Silver

    22.30
    -0.04 (-0.17%)
     
  • EUR/USD

    1.1710
    -0.0022 (-0.19%)
     
  • 10-Yr Bond

    1.3700
    0.0000 (0.00%)
     
  • Vix

    25.89
    +7.20 (+38.52%)
     
  • GBP/USD

    1.3659
    -0.0078 (-0.57%)
     
  • USD/JPY

    109.5130
    -0.3820 (-0.35%)
     
  • BTC-USD

    43,721.66
    -3,631.37 (-7.67%)
     
  • CMC Crypto 200

    1,087.40
    -138.13 (-11.27%)
     
  • FTSE 100

    6,845.93
    -117.71 (-1.69%)
     
  • Nikkei 225

    30,500.05
    +176.75 (+0.58%)
     

Photo of Biohaven Pharmaceuticals Ringing the Opening Bell Available on Business Wire's Website and the Associated Press Photo Network

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

A photo is available on Business Wire's website and the Associated Press Photo Network of Biohaven Pharmaceuticals (NYSE: BHVN) ringing the opening bell, June 8, 2021. BJ Jones, Chief Commercial Officer, Migraine & Common Disease and Vlad Coric, M.D., Chief Executive Officer of Biohaven ring the opening bell at the New York Stock Exchange in support of the migraine community and Migraine and Headache Awareness Month and to celebrate the FDA approval of the first and only medicine to treat and prevent migraine.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210608005948/en/

BJ Jones, Chief Commercial Officer, Migraine & Common Disease and Vlad Coric, M.D., Chief Executive Officer of Biohaven ring the opening bell at the New York Stock Exchange in support of the migraine community and Migraine and Headache Awareness Month and to celebrate the FDA approval of the first and only medicine to treat and prevent migraine. (Photo: NYSE)

View source version on businesswire.com: https://www.businesswire.com/news/home/20210608005948/en/

Contacts

Mike Beyer
Sam Brown Inc.
312-961-2502
mikebeyer@sambrown.com